Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library brexucabtagene autoleucel

brexucabtagene autoleucel

Pronunciation: BREX ue KAB ta jeen AH toe LOO sel

Brand: Tecartus

What is the most important information I should know about brexucabtagene autoleucel?

What is the most important information I should know about brexucabtagene autoleucel?

A common but serious side effect of this medicine is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.

What is brexucabtagene autoleucel?

What is brexucabtagene autoleucel?

Brexucabtagene autoleucel is an immunotherapy medicine used to treat mantle cell lymphoma in adults. This medicine is given after other treatments did not work or have stopped working.

Brexucabtagene autoleucel is made using white blood cells removed from blood that is drawn from your body through a vein.

Brexucabtagene autoleucel may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving brexucabtagene autoleucel?

What should I discuss with my healthcare provider before receiving brexucabtagene autoleucel?

You should not be treated with this medicine while you have an active infection (such as fever, chills, flu-like symptoms).

Tell your doctor if you have ever had:

  • an active or chronic infection;
  • a stroke;
  • a seizure;
  • memory problems;
  • breathing problems;
  • hepatitis B or C;
  • HIV;
  • heart problems;
  • liver disease;
  • kidney disease; or
  • if you have received a vaccine within the past 6 weeks.

Using brexucabtagene autoleucel may increase your risk of developing other cancers, such as leukemia. Ask your doctor about this risk.

You may need to have a negative pregnancy test before starting this treatment.

Tell your doctor if you are pregnant. Brexucabtagene autoleucel may harm an unborn baby. Use effective birth control to prevent pregnancy. Talk with your doctor if you plan to become pregnant after you are treated with this medicine.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

How is brexucabtagene autoleucel given?

How is brexucabtagene autoleucel given?

Brexucabtagene autoleucel is available only at an authorized hospital or clinic, and must be given by specially trained healthcare professionals.

Brexucabtagene autoleucel is given after a procedure called leukapheresis (LOO-kuh-fuh-REE-sis).

During leukapheresis, some of your blood is collected through a small tube (catheter) placed into a vein. The catheter is connected to a machine that separates your white blood cells from other parts of the blood.

The cells are then sent to a laboratory where they are made into brexucabtagene autoleucel. Because it will take time to process your blood cells into brexucabtagene autoleucel, you will not receive the medicine on the same day your blood cells are drawn.

Beginning 5 days before this medicine is given, you will be pre-treated with chemotherapy to help prepare your body for brexucabtagene autoleucel.

About 30 to 60 minutes before you receive brexucabtagene autoleucel, you will be given other medications to help prevent serious side effects or allergic reaction.

Once your body is ready to receive brexucabtagene autoleucel, your care providers will inject the medicine as an infusion into a vein.

Your doctor will need to check your progress on a daily basis for at least 7 days after the infusion.

For at least 4 weeks, plan to stay near the hospital or clinic where you received brexucabtagene autoleucel.

Brexucabtagene autoleucel affects your immune system. You may get infections more easily, even serious or fatal infections.

If you've ever had hepatitis B, using brexucabtagene autoleucel can cause this virus to become active or get worse. You may need frequent liver function tests.

Brexucabtagene autoleucel can have long lasting effects on your body. You may need frequent medical tests while using this medicine and for a short time after your last dose.

What happens if I miss a dose?

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your pre-treatment chemotherapy. The timing of your chemotherapy and brexucabtagene autoleucel injection is very important to the success of your treatment for mantle cell lymphoma.

What happens if I overdose?

What happens if I overdose?

Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid after receiving brexucabtagene autoleucel?

What should I avoid after receiving brexucabtagene autoleucel?

This medicine can cause weakness, drowsiness, confusion, problems with memory or coordination, and seizures. Avoid driving or operating machinery for at least 8 weeks after you are treated with brexucabtagene autoleucel.

Ask your doctor before you receive a "live" vaccine. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible side effects of brexucabtagene autoleucel?

What are the possible side effects of brexucabtagene autoleucel?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

A common but serious side effect of this medicine is called cytokine release syndrome (CRS). Tell your caregivers right away if you have signs of this condition: fever, chills, dizziness, confusion, vomiting, diarrhea, fast heartbeats, trouble breathing, or feeling very weak or tired. Your caregivers will have medication available to quickly treat CRS if it occurs.

Call your doctor at once if you have:

  • severe drowsiness;
  • trouble speaking or writing;
  • trouble with daily activities;
  • a seizure;
  • severe ongoing nausea, vomiting, or diarrhea;
  • low blood cell counts --fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;
  • kidney problems --little or no urination, swelling in your feet or ankles, feeling tired or short of breath; or
  • fluid build-up in or around the lungs --pain when you breathe, feeling short of breath while lying down, wheezing, gasping for breath, cough with foamy mucus, cold and clammy skin, anxiety, rapid heartbeats.

You may need to be treated in a hospital if you have certain side effects.

Common side effects may include:

  • slurred speech;
  • fever, chills, cough, or other signs of infection;
  • feeling tired or light-headed;
  • fast or irregular heartbeats;
  • tremor, problems with speech or muscle movement;
  • headache, muscle or joint pain;
  • nausea, loss of appetite;
  • diarrhea, constipation;
  • swelling, kidney problems;
  • rash; or
  • sleep problems (insomnia).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect brexucabtagene autoleucel?

What other drugs will affect brexucabtagene autoleucel?

Other drugs may affect brexucabtagene autoleucel, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Where can I get more information?

Where can I get more information?

Your pharmacist can provide more information about brexucabtagene autoleucel.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

Cigna Company Information

About Cigna Company Profile Careers Newsroom Investors Suppliers Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice [PDF] Language Assistance [PDF] Report Fraud Sitemap

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., and Cigna HealthCare of North Carolina, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities  that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details